Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Holdings, Inc. is a biotechnology company that provides biological research and development services and tools rather than manufacturing end products. It operates through two segments: cell engineering and biosecurity. In cell engineering, Ginkgo offers research services, automated laboratory hardware, computational models, and biological data assets to support the discovery, optimization, and production of biological products. In biosecurity, it provides biomonitoring programs via Canopy and threat surveillance and analytics through Horizon. Ginkgo serves commercial clients in pharmaceuticals, biotechnology, agriculture, and industrial biotech, as well as government agencies.

Headquartered in Boston, the company coordinates operations and analyzes data from an international partner network. Its facilities include an automated laboratory, up to 3,000 liters of pilot fermentation capacity, and an approximately 12,000-square-foot greenhouse. The company also maintains a collection of over 315,000 agricultural microorganisms and a metagenomic library of more than 2.7 billion genes. Ginkgo deploys biosecurity sampling nodes at strategic locations such as airports and border checkpoints globally.

Summary of the business section of Ginkgo Bioworks's latest annual report, written by StockData.

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

“As of December 31, 2025 we had 485 employees.”